Impact of Fungi on Immune Responses

Clinical Therapeutics

Volumn 40, Issue 6, 2018, Pages 885-888

  Conti, Pio ^a   Tettamanti, Lucia ^b   Mastrangelo, Filiberto ^c   Ronconi, Gianpaolo ^d   Frydas, Ilias ^e   Kritas, Spiros K ^e   Caraffa, Alessandro ^f   Pandolfi, Franco ^g  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

^d FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^e ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^f UNIVERSITY OF PERUGIA   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

Author keywords

cytokines; fungi; infection; inflammation; innate immunity; macrophages; mast cells; mold; mycotoxins

Indexed keywords

INTERLEUKIN 37; CYTOKINE;

ARTICLE; FUNGUS; FUNGUS IMMUNITY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PROTEIN FUNCTION; DENDRITIC CELL; IMMUNOLOGY; MACROPHAGE; MAST CELL; MYCOSIS;

CYTOKINES; DENDRITIC CELLS; FUNGI; HUMANS; MACROPHAGES; MAST CELLS; MYCOSES;

EID: 85046699376     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2018.04.010     Document Type: Article

References (41)

1. Nair, D.N., Padmavathy, S., Impact of endophytic microorganisms on plants, environment and humans. ScientificWorldJournal, 2014, 2014, 250693.
2. Park, J.H., Cox-Ganser, J.M., Mold exposure and respiratory health in damp indoor environments. Front Biosci (Elite Ed) 3 (2011), 757–771.
3. Vacher, G., Niculita-Hirzel, H., Roger, T., Immune responses to airborne fungi and non-invasive airway diseases. Semin Immunopathol 37 (2015), 83–96.
4. Knutsen, A.P., Bush, R.K., Demain, J.G., et al. Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol 129 (2012), 280–291 quiz 292-3.
5. Ghosh, S., Hoselton, S.A., Dorsam, G.P., Schuh, J.M., Eosinophils in fungus-associated allergic pulmonary disease. Front Pharmacol, 4, 2013, 8.
6. Moloney NM, Owens RA, Doyle S. Proteomic analysis of Aspergillus fumigatus - clinical implications. Expert Rev Proteomics.13:635-649.
7. Chrenkova, V., Hubka, V., Cetkovsky, P., et al. Proven Invasive Pulmonary Aspergillosis in Stem Cell Transplant Recipient Due to Aspergillus sublatus, a Cryptic Species of A. nidulans. Mycopathologia 183 (2018), 423–429.
8. Blatzer, M., Latgé J.P., Metal-homeostasis in the pathobiology of the opportunistic human fungal pathogen Aspergillus fumigatus. Curr Opin Microbiol 40 (2017), 152–159.
9. LeibundGut-Landmann, S., Wüthrich, M., Hohl, T.M., Immunity to fungi. Curr Opin Immunol 24 (2012), 449–458.
10. Taghavi, M., Khosravi, A., Mortaz, E., et al. Role of pathogen-associated molecular patterns (PAMPS) in immune responses to fungal infections. Eur J Pharmacol 808 (2017), 8–13.
11. Franzenburg, S., Fraune, S., Künzel, S., et al. MyD88-deficient Hydra reveal an ancient function of TLR signaling in sensing bacterial colonizers. Proc Natl Acad Sci U S A 109 (2012), 19374–19379.
12. Plato, A., Hardison, S.E., Brown, G.D., Pattern recognition receptors in antifungal immunity. Semin Immunopathol 37 (2015), 97–106.
13. Zuo, L., Lucas, K., Fortuna, C.A., et al. Molecular Regulation of Toll-like Receptors in Asthma and COPD. Front Physiol, 6, 2015, 312.
14. Konno, H., Yamamoto, T., Yamazaki, K., et al. TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA. PLoS ONE, 4, 2009, e5674.
15. Pennini, M.E., Perkins, D.J., Salazar, A.M., et al. Complete dependence on IRAK4 kinase activity in TLR2, but not TLR4, signaling pathways underlies decreased cytokine production and increased susceptibility to Streptococcus pneumoniae infection in IRAK4 kinase-inactive mice. J Immunol 190 (2013), 307–316.
16. Sha, Y., Markovic-Plese, S., A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases. Self Nonself 2 (2011), 35–42.
17. Isailovic, N., Daigo, K., Mantovani, A., Selmi, C., Interleukin-17 and innate immunity in infections and chronic inflammation. J Autoimmun 60 (2015), 1–11.
18. Carrier, Y., Ma, H.L., Ramon, H.E., et al. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol 131 (2011), 2428–2437.
19. Gresnigt, M.S., Rösler, B., Jacobs, C.W., et al. The IL-36 receptor pathway regulates Aspergillus fumigatus-induced Th1 and Th17 responses. Eur J Immunol 43 (2013), 416–426.
20. Ebrahimpour, S., Shahbazi, M., Khalili, A., et al. Elevated levels of IL-2 and IL-21 produced by CD4+ T cells in inflammatory bowel disease. J Biol Regul Homeost Agents 31 (2017), 279–287.
21. Amaral, R.C., Barbeiro, D.F., Koike, M.K., et al. Cytokine and chemokine levels in the heart tissue of aged rats following severe acute pancreatitis. Eur J Inflamm 15 (2017), 102–106.
22. Marinari, S., De Iuliis, V., Dadorante, V., et al. Cytokine modulation in patients with idiopathic pulmonary fibrosis undergoing treatment with steroids, immunosuppressants, and IFN-γ 1b. J Biol Regul Homeost Agents 31 (2017), 59–69.
23. Garlanda, C., Dinarello, C.A., Mantovani, A., The interleukin-1 family: back to the future. Immunity 39 (2013), 1003–1018.
24. Rivera-Mariani, F.E., Vysyaraju, K., Negherbon, J., et al. Comparison of the interleukin-1β-inducing potency of allergenic spores from higher fungi (basidiomycetes) in a cryopreserved human whole blood system. Int Arch Allergy Immunol 163 (2014), 154–162.
25. Conti, C., Caraffa, A., Kritas, S.K., et al. Alexithymia and its relationships with inflammatory response mediated by IL-1 family members. J Biol Regul Homeost Agents 31 (2017), 21–28.
26. Galli, S.J., Kalesnikoff, J., Grimbaldeston, M.A., et al. Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23 (2005), 749–786.
27. Theoharides, T.C., Valent, P., Akin, C., Mast cells, mastocytosis and related disorders. New Engl J Med 373 (2015), 163–172.
28. Conti, P., Caraffa, A. l, Kritas, S.K., et al. Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues. J Biol Regul Homeost Agents 31 (2017), 263–267.
29. Lopes, J.P., Stylianou, M., Nilsson, G., Urban, C.F., Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells. Sci Rep, 5, 2015, 12287.
30. Saluja, R., Metz, M., Maurer, M., Role and relevance of mast cells in fungal infections. Front Immunol, 3, 2012, 146.
31. Carroll-Portillo, A., Cannon, J.L., te Riet, J., et al. Mast cells and dendritic cells form synapses that facilitate antigen transfer for T cell activation. J Cell Biol 210 (2015), 851–864.
32. Galli, S.J., Gaudenzio, N., Human mast cells as antigen-presenting cells: When is this role important in vivo?. J Allergy Clin Immunol 141 (2018), 92–93.
33. Kandere-Grzybowska, K., Letourneau, R., Kempuraj, D., et al. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol 171 (2003), 4830–4836.
34. Taracanova, A., Alevizos, M., Karagkouni, A., et al. SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors. Proc Natl Acad Sci U S A 114 (2017), E4002–E4009.
35. Girolamo, F., Coppola, C., Ribatti, D., Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases. Brain Behav Immun 65 (2017), 68–89.
36. Quigley, E.M.M., Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Curr Neurol Neurosci Rep, 17, 2017, 94.
37. Boraschi, D., Lucchesi, D., Hainzl, S., et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 22 (2011), 127–147.
38. Conti, P., Carinci, F., Lessiani, G., et al. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells. Immunol Res 65 (2017), 982–986.
39. Carinci, F., Lessiani, G., Spinas, E., et al. Mast cell and cancer with special emphasis on Il-37 an anti-inflammatory and inhibitor of innate immunity: new frontiers. J Biol Regul Homeost Agents 30 (2016), 945–950.
40. Zhan, Q., Zeng, Q., Song, R., et al. IL-37 suppresses MyD88-mediated inflammatory responses in human aortic valve interstitial cells. Mol Med, 2017, 23.
41. Ravikumar, S., Win, M.S., Chai, L.Y., Optimizing outcomes in immunocompromised hosts: understanding the role of immunotherapy in invasive fungal diseases. Front Microbiol, 6, 2015, 1322.